Line K.
- Country
- Denmark
- Department
- Department of Ophthalmology
Research Overview
- Long-Term Safety and Efficacy Assessment of Botaretigene Sparoparvovec in X-Linked Retinitis Pigmentosa with RPGR Gene Variants
- Evaluation of Ultevursen Efficacy, Safety, and Tolerability in Retinitis Pigmentosa Patients with USH2A Exon 13 Mutations: A Double-Masked, Randomized, Sham-Controlled Trial
Data & Insights
Has run more than one trial at 6 of 12 partner sites.
Specializations
Retinal Disorders
This investigator specializes in treating X-linked retinitis pigmentosa, focusing particularly on cases involving RPGR gene mutations. Their expertise extends to understanding progressive vision reduction patterns and genetic factors affecting retinal health.
- Inherited Retinal Diseases
- X-Chromosome Related Vision Disorders
- Progressive Vision Loss Conditions
Their research encompasses retinal degeneration patterns and genetic mechanisms of vision loss.
Gene Therapy Applications
The investigator has developed expertise in advanced gene therapy treatments, particularly utilizing AAV5 viral vectors for ocular conditions. Their work focuses on developing therapeutic approaches for genetic vision disorders.
- Viral Vector-Based Therapies
- Genetic Treatment Protocols
- Long-term Therapeutic Solutions
Their research involves evaluating innovative genetic interventions for inherited eye conditions.
Vision Assessment
The investigator specializes in evaluating functional vision outcomes through sophisticated assessment methods, including vision-guided mobility assessment. Their expertise includes tracking long-term vision changes and treatment efficacy.
- Mobility-Based Vision Testing
- Long-term Vision Monitoring
- Safety and Efficacy Assessment
Their work involves comprehensive evaluation of vision function and treatment outcomes.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.